Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TBPHTBPH
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in THERAVANCE BIOPHARMA INC

GOLDMAN SACHS GROUP INC holds 416,143 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $6.8M as of 2026-Q1. The position was increased (+43.1% shares). TBPH represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$6.8M

Current Shares

416,143

Total Value Change

+$4.6M

Total Shares Change

+191,040

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
416,143
+43.1%
$6.8M0.0%$13.96
37
2025-Q4
Increased
290,864
+12.5%
$5.4M0.0%$18.91
30
2025-Q3
Increased
258,648
+29.7%
$3.8M0.0%$14.43
34
2025-Q2
Decreased
199,386
-5.3%
$2.2M0.0%$11.22
0
2025-Q1
Decreased
210,536
-6.5%
$1.9M0.0%$9.23
0
2024-Q4
New
225,103
-
$2.1M0.0%$9.47
36

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used